Researchers seek clues to brain swelling after aneurysm
The rupture of an aneurysm in the brain triggers an immune response that activates white blood cells to produce specific proteins. Overproduction of the protein LRG1 is associated with complications after subarachnoid hemorrhage including more cerebral edema and worse neurological…
University launches advanced PET/MRI imaging service
UTHealth Houston has launched a state-of-the-art PET/MRI imaging service, bringing together two advanced imaging technologies into a single integrated platform designed to enhance precision cancer care, support clinical research, and expand opportunities in molecular imaging. The service combines positron emission…
Institute of Perioperative Medicine celebrates first year, advances
Each year, millions of patients survive surgery only to face a different and often overlooked threat: organ failure in the days that follow. Perioperative death remains the third leading cause of death in the United States, behind heart disease and…
Pilot study examines how disrupted eating patterns may fuel chronic inflammation
A new pilot project, funded by the Texas Medical Center Digestive Diseases Center Pilot Feasibility Award, explores how lifestyle habits tied to the body’s internal clock may shape gut health and influence the development of age-related disease. Led by Xiangsheng…
Research study links anti-aging protein to chronic disease protection
A protein long studied for its connection to aging may also play a key role in protecting the body from chronic disease, according to new research from the laboratory of Mikhail Kolonin, PhD, published in Aging Cell (external link). Telomerase…
McGovern researchers lead two of three newly funded CPRIT projects
Two McGovern Medical School at UTHealth Houston researchers are leading newly funded projects among three UTHealth Houston awards from the Cancer Prevention and Research Institute of Texas, securing more than $6 million to advance cancer treatment, prevention, and translational research…
UTHealth Houston study suggests new target for metastatic breast cancer treatments
A peptide that successfully targeted and killed metastatic cancer cells in mice may open the door to developing more efficient ways to detect and treat metastatic breast cancer in humans, UTHealth Houston researchers have discovered. The research was published in Molecular…
Bludworth, Traylor honored with national laboratory management awards
Two UTHealth Houston laboratory animal care professionals earned national honors for leadership in research support and management, a first for the university. Jacqueline Bludworth and Cneshia Traylor, from Laboratory Animal Medicine and Care, were honored at the 2026 Laboratory Animal…
Tumor-on-a-chip brings new insight to pancreatic cancer
Pancreatic cancer remains one of the most difficult cancers to treat, in large part because tumors do not exist in isolation. Instead, they are surrounded by a dense and complex network of blood vessels, connective tissue, and immune cells that…
UTHealth Houston-developed cancer therapy platform takes major step toward clinical translation
CrossBridge Bio, a biotechnology company developing next-generation antibody-drug conjugates based on discoveries by researchers at UTHealth Houston, is taking a major step toward clinical translation after being acquired by Eli Lilly. The dual-payload antibody-drug conjugate technology was originally created by…